Table 1.

The characteristics of patients enrolled to the study.

Patient Characteristics
Age—median (range)	61 years (31–80)
Male—number of patients (median of age; range)	17 (57 years; 32–80)
Female—number of patients (median of age; range)	19 (66 years;31–76)
Patients with metastatic disease—number of patients (%)	27 (75%)
Patients without metastases—number of patients (%)	9 (25%)
Patients with carcinoid syndrome—number of patients (%)	7 (19%)
Patients with non-functioning NETs—number of patients (%)	29 (81%)
Type of NETs—number of patients (%)
foregut	11 (31%)
midgut	12 (33%)
hindgut	6 (17%)
unknown or others	7 (19%)
Localization of the primary tumor—number of patients (%)
lung	6 (17%)
thymus	1 (3%)
pancreas	2 (6%)
stomach	2 (6%)
small intestine and appendix	12 (33%)
rectum	6 (17%)
unknown or others	7 (19%)
Concurrent SST analogs—number of patients (%)	14 (39%)